Literature DB >> 12801227

Discovery and structural modification of inhibitors of methionine aminopeptidases from Escherichia coli and Saccharomyces cerevisiae.

Qun-Li Luo1, Jing-Ya Li, Zhi-Ying Liu, Ling-Ling Chen, Jia Li, Zhen Qian, Qiang Shen, Yu Li, Gerald H Lushington, Qi-Zhuang Ye, Fa-Jun Nan.   

Abstract

A series of pyridine-2-carboxylic acid derivatives were synthesized according to the leads from the screening, and potent inhibitors have been obtained by structural modification. They have shown submicromolar inhibition of the enzymes (for example, for 9n, IC(50) = 130 nM for EcMetAP1 and IC(50) = 380 nM for ScMetAP1). They represent small-molecule MetAP inhibitors with novel structures different from alkylating fumagillin derivatives and peptidic bestatin-based MetAP inhibitor.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12801227     DOI: 10.1021/jm0300532

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  24 in total

1.  Protein N-terminal processing: substrate specificity of Escherichia coli and human methionine aminopeptidases.

Authors:  Qing Xiao; Feiran Zhang; Benjamin A Nacev; Jun O Liu; Dehua Pei
Journal:  Biochemistry       Date:  2010-07-06       Impact factor: 3.162

2.  Elucidation of the function of type 1 human methionine aminopeptidase during cell cycle progression.

Authors:  Xiaoyi Hu; Anthony Addlagatta; Jun Lu; Brian W Matthews; Jun O Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-17       Impact factor: 11.205

3.  Synthesis and biological evaluation of salicylate-based compounds as a novel class of methionine aminopeptidase inhibitors.

Authors:  Wen-Long Wang; Sergio C Chai; Qi-Zhuang Ye
Journal:  Bioorg Med Chem Lett       Date:  2011-09-24       Impact factor: 2.823

4.  A Bioinorganic Approach to Fragment-Based Drug Discovery Targeting Metalloenzymes.

Authors:  Seth M Cohen
Journal:  Acc Chem Res       Date:  2017-07-17       Impact factor: 22.384

5.  Inhibition of monometalated methionine aminopeptidase: inhibitor discovery and crystallographic analysis.

Authors:  Min Huang; Sheng-Xue Xie; Ze-Qiang Ma; Qing-Qing Huang; Fa-Jun Nan; Qi-Zhuang Ye
Journal:  J Med Chem       Date:  2007-10-19       Impact factor: 7.446

Review 6.  Targeting Metalloenzymes for Therapeutic Intervention.

Authors:  Allie Y Chen; Rebecca N Adamek; Benjamin L Dick; Cy V Credille; Christine N Morrison; Seth M Cohen
Journal:  Chem Rev       Date:  2018-09-07       Impact factor: 60.622

7.  Growth inhibition of Escherichia coli and methicillin-resistant Staphylococcus aureus by targeting cellular methionine aminopeptidase.

Authors:  Sergio C Chai; Wen-Long Wang; De-Rong Ding; Qi-Zhuang Ye
Journal:  Eur J Med Chem       Date:  2011-05-05       Impact factor: 6.514

8.  Expression and characterization of Mycobacterium tuberculosis methionine aminopeptidase type 1a.

Authors:  Jing-Ping Lu; Qi-Zhuang Ye
Journal:  Bioorg Med Chem Lett       Date:  2010-03-19       Impact factor: 2.823

9.  FE(II) is the native cofactor for Escherichia coli methionine aminopeptidase.

Authors:  Sergio C Chai; Wen-Long Wang; Qi-Zhuang Ye
Journal:  J Biol Chem       Date:  2008-07-31       Impact factor: 5.157

10.  Discovery of inhibitors of Escherichia coli methionine aminopeptidase with the Fe(II)-form selectivity and antibacterial activity.

Authors:  Wen-Long Wang; Sergio C Chai; Min Huang; Hong-Zhen He; Thomas D Hurley; Qi-Zhuang Ye
Journal:  J Med Chem       Date:  2008-09-12       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.